Profile

Nathan Cherrington

Pharmacology and Toxicology

Full Page

Overview

Research

Collaboration(45)

Page 1 of 9

Grants(21)

Training in Environmental Toxicology of Human Disease
Active·2024·$28.2M / $671.6K·
External
Principal Investigator (PI)
environmental toxicology, human disease, training, environmental health, medical education
Southwest Environmental Health Sciences Center
Active·2023·$1.1M / $3.1M·
External
Principal Investigator (PI)
environmental health, biomedical research, environmental sciences, public health, epidemiology
Glyphosate Impairs Glucose Homeostasis via Gut Microbiome Induced Alterations to Bile Acid Signaling
Active·2023·$0 / $91.8K·
External
Co-Investigator (COI)
glyphosate, glucose homeostasis, gut microbiome, bile acid signaling, metabolism
MegaTrans - Human Transporter Machine Learning Models
Active·2022·$700K·
External
Principal Investigator (PI)
transportation, machine learning, human interaction, technology, modeling
Training in Environmental Toxicology of Human Disease
Active·2019·$3.1M·
External
Principal Investigator (PI)
environmental toxicology, human disease, training, environmental health, toxicological mechanisms

Page 1 of 5

Publications(148)

Recent

Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development

2023

drug discovery, nucleoside transporters, clinical importance, development, equilibrative

Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis

2023

rodent models, renal transporter alterations, nonalcoholic steatohepatitis, human, research

Drug Transporters at the Human Blood-Testis Barrier

2023

drug transporters, blood-testis barrier, human, drug transport, barrier function

Excretion of polybrominated diphenyl ethers and AhR activation in breastmilk among firefighters

2023

excretion, polybrominated diphenyl ethers, ahr activation, breastmilk, firefighters

Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine

2023

antiviral drugs, transporter inhibition, drug interaction, pharmacokinetics, drug efficacy

Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients

2023

drug pharmacokinetics, adverse drug reactions, nonalcoholic steatohepatitis, predicting disruptions, risk assessment

In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier

2023

drug transport, blood-testis barrier, in vivo models, in vitro models, drug development

Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier

2022

male contraception, blood-testis barrier, transporter-mediated uptake, physiological characterization, reversible contraceptive

Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations.

2022

liver disease, pharmacokinetics, diagnostic techniques, nonalcoholic fatty liver disease, medical imaging

Increased Renal Expression of Complement Components in Patients With Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination

2022

renal disease, complement system, liver disease, inflammatory response, viral hepatitis

People

Profile

Nathan Cherrington

Collaboration(45)

Walter Klimecki

H-H. Sherry Chow

Fernando Martinez

Jefferey Burgess

David Besselsen

Grants(21)

Training in Environmental Toxicology of Human Disease

Southwest Environmental Health Sciences Center

Glyphosate Impairs Glucose Homeostasis via Gut Microbiome Induced Alterations to Bile Acid Signaling

MegaTrans - Human Transporter Machine Learning Models

Training in Environmental Toxicology of Human Disease

Publications(148)

Addressing the Clinical Importance of Equilibrative Nucleoside Transporters in Drug Discovery and Development

Representative Rodent Models for Renal Transporter Alterations in Human Nonalcoholic Steatohepatitis

Drug Transporters at the Human Blood-Testis Barrier

Excretion of polybrominated diphenyl ethers and AhR activation in breastmilk among firefighters

Transporter Inhibition Profile for the Antivirals Tilorone, Quinacrine and Pyronaridine

Predicting disruptions to drug pharmacokinetics and the risk of adverse drug reactions in non-alcoholic steatohepatitis patients

In Vitro and In Vivo Models for Drug Transport Across the Blood-Testis Barrier

Physiological Characterization of the Transporter-Mediated Uptake of the Reversible Male Contraceptive H2-Gamendazole Across the Blood-Testis Barrier

Strategies to Diagnose Nonalcoholic Steatohepatitis: A Novel Approach to Take Advantage of Pharmacokinetic Alterations.

Increased Renal Expression of Complement Components in Patients With Liver Diseases: Nonalcoholic Steatohepatitis, Alcohol-Associated, Viral Hepatitis, and Alcohol-Viral Combination